✦ LIBER ✦

Comparing the efficacy of cyclooxygenase 2–specific inhibitors in treating osteoarthritis: Appropriate trial design considerations and results of a randomized, placebo-controlled trial

✍ Scribed by Allan Gibofsky; Gary W. Williams; Frank McKenna; John G. Fort

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 124 KB
Volume: 48
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.11330

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rofecoxib, a specific inhibitor of cyclo

Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: Results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip

✍ Grant W. Cannon; Jacques R. Caldwell; Peter Holt; Barry McLean; Beth Seidenberg; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

Comparison of the effect of rofecoxib (a

Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial

✍ Christopher Hawkey; Loren Laine; Thomas Simon; Andre Beaulieu; Jose Maldonado-Co 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 2 views

Safety and efficacy of long-term intraar

Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: A randomized, double-blind, placebo-controlled trial

✍ Jean-Pierre Raynauld; Chris Buckland-Wright; Rupert Ward; Denis Choquette; Boulo 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

The effectiveness of pulsed electrical s

The effectiveness of pulsed electrical stimulation in the management of osteoarthritis of the knee: Results of a double-blind, randomized, placebo-controlled, repeated-measures trial

✍ Robyn E. Fary; Graeme J. Carroll; Tom G. Briffa; N. K. Briffa 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 2 views

The safety and efficacy of a JAK inhibit

The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo

✍ Joel M. Kremer; Bradley J. Bloom; Ferdinand C. Breedveld; John H. Coombs; Mark P 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 2 views

The efficacy and safety of rituximab in

The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial

✍ Paul Emery; Roy Fleischmann; Anna Filipowicz-Sosnowska; Joy Schechtman; Leszek S 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 2 views